Hypothesis

Digital twin models that integrate epigenetic age clocks (e.g., GrimAge) with proteomic inflammation signatures can forecast a critical threshold at which inflammaging transitions from a low‑grade, adaptive state to a pathogenic, self‑reinforcing regime. Crossing this threshold predicts accelerated multi‑system decline and is modifiable by timely interventions.

Mechanistic Rationale

1. Temporal layering of omics signals – Epigenetic clocks exhibit high intra‑individual stability and reflect cumulative biological age, whereas proteomic clocks capture recent physiological fluctuations 1. Inflammaging, defined by sustained upregulation of immune pathways, shows divergent dynamics across layers: early epigenetic drift primes cells for heightened NF-kB responsiveness, while subsequent proteomic surges of cytokines (IL-6, TNF-a, CRP) mark the effector phase 3.

2. Feedback loop hypothesis – We propose that epigenetic alterations at promoters of immune‑regulatory genes (e.g., hypomethylation of IL6 enhancer) lower the activation threshold for inflammasome signaling. Once proteomic cytokine levels exceed a tissue‑specific set point, they reinforce further epigenetic remodeling via ROS‑mediated TET inhibition, creating a bistable switch.

3. Digital twin parameterization – By feeding longitudinal epigenetic and proteomic measurements into a multiscale agent‑based model, the twin can locate the bifurcation point where the system's Jacobian eigenvalue crosses zero, indicating loss of homeostasis 2.

Testable Predictions

• Prediction 1: Individuals whose epigenetic age residual (difference between GrimAge and chronological age) exceeds +5 years will show a 2‑fold increase in plasma IL-6 trajectory slope over the next 2 years compared with those below this threshold.
• Prediction 2: In simulated digital twin trajectories, interventions that reduce proteomic IL-6 by 30% before the predicted threshold will delay the inflammaging switch by ≥5 years, whereas the same intervention after threshold crossing yields <1 year delay.
• Prediction 3: Single‑cell multi‑omics from peripheral blood mononuclear cells collected before and after the predicted threshold will reveal coordinated loss of methylation at NF-kB target loci and a concomitant surge in intracellular cytokine protein levels.

Experimental Design

1. Cohort: Recruit 500 adults aged 45‑70 with baseline epigenome (Illumina EPIC), proteomics (SomaScan v4), and clinical data; follow for 4 years with annual visits.
2. Digital twin construction: Use unsupervised clustering to define aging subtypes; train a Bayesian network that maps epigenetic residual → proteomic cytokine trajectory → clinical frailty index.
3. Threshold detection: Apply change‑point analysis to each twin’s simulated cytokine trajectory; validate against observed clinical outcomes (e.g., incident CVD, diabetes).
4. Intervention arm: Randomize high‑risk twins to receive either lifestyle modification (exercise + Mediterranean diet) or placebo; assess whether early intervention shifts the predicted threshold.
5. Validation: Perform targeted bisulfite sequencing and intracellular cytokine staining on sorted CD14+ monocytes at predicted switch points.

Implications

If confirmed, this hypothesis would provide a mechanistic bridge between static epigenetic age and dynamic proteomic inflammation, enabling digital twins to prescribe pre‑emptive windows for anti‑inflammaging therapies. It also generates a falsifiable marker (the epigenetic‑proteomic threshold) that can be refined across populations, addressing current limitations in model generalizability and intervention timing.

References

[1] context – https://pmc.ncbi.nlm.nih.gov/articles/PMC12371080/ [2] LifeTIME framework – https://arxiv.org/abs/2510.12384 [3] Inflammaging multi‑tissue epigenetics – https://doi.org/10.1101/gr.240093.118 [4] Research protocols for digital twin – https://www.researchprotocols.org/2022/5/e35738